Thus, interactions with the tumor microenvironment can result in deregulation of estrogen receptor signaling and alterations in cell survival signaling molecules that provide tumors with alternative proliferative and survival stimuli [53]–[55]. The gene discussed is ESR1; the disease is neoplasm.